Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon International Regulatory News (PIN)

Share Price Information for Pantheon International (PIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 329.50
Bid: 328.00
Ask: 329.50
Change: 3.00 (0.92%)
Spread: 1.50 (0.457%)
Open: 328.00
High: 330.00
Low: 325.00
Prev. Close: 326.50
PIN Live PriceLast checked at -
Pantheon International is an Investment Trust

To maximise capital growth by investing in a diversified portfolio of private equity funds and occasionally directly in private companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Performance Update

22 Aug 2018 07:00

RNS Number : 4849Y
Pantheon International PLC
22 August 2018
 

22 August 2018

 

Pantheon International Plc

Performance Update at 31 July 2018

 

 

Month to 31 July 2018

 

PIP announced an unaudited net asset value ("NAV") per share at 31 July 2018 of 2,463.4p, an increase of 24.6p (1.0%) from the NAV per share as at 30 June 2018. Valuation gains* (10.1p, 0.4%), investment income* (1.1p, 0.0%) and foreign exchange movements* (16.5p, 0.7%) were partially offset by expenses and taxes** (-3.1p, -0.1%).

PIP's valuation policy for private equity funds is based on the latest valuations reported by the managers of the funds in which PIP has holdings. In the case of PIP's valuation as at 31 July 2018, 100% of reported valuations are dated 31 March 2018 or later.

At 31 July 2018, PIP's private equity assets stood at £1,314m, whilst net available cash balances*** were £132m. The Asset Linked Note**** ("ALN") outstanding as at 31 July 2018 amounted to £113m. Undrawn commitments to investments stood at £469m as at 31 July 2018, calculated using exchange rates at that date. PIP's multi-currency revolving credit facilities comprise a US$163.0m facility and a €59.8m facility, which remained completely undrawn as at 31 July 2018.

 

PIP's portfolio generated net cash* of £4.4m during the month, with distributions of £16.1m relative to £11.7m of calls from existing commitments to private equity funds.

 

PIP committed £34.0m to new investments in July. This included a £15.0m primary commitment to ECI 11, a UK mid-market buyout fund, and a £10.7m primary commitment to Baring Asia Private Equity Fund VII, an Asian buyout fund. PIP also committed £8.3m to three co-investments: £3.2m alongside Francisco Partners in Renaissance Learning, a provider of K-12 digital learning solutions; £3.2m alongside Oak HC/FT Associates in Therapy Brands, a provider of practice management solutions for the behavioural health market segment; and, £1.9m alongside Hellman and Friedman Capital Management in Financial Engines, a leading provider of automated, personalised investment management services to individuals in employer-sponsored personal pension plans in the USA.

 

* Figures are stated net of movements associated with the ALN share of the reference portfolio.

**Withholding taxes on investment distributions.

*** Net available cash calculated as cash and net current assets/(liabilities) less undistributed net cashflows associated with the ALN.

****Unlisted 10-year note issued on 31 October 2017 whose cost and repayments are linked to a reference portfolio consisting of the Company's older vintage funds.

 

 

 

 

Monthly Report

The July monthly newsletter can be accessed on PIP's website at www.piplc.com in the Investor Relations section under the heading "Newsletters", or by following this link: http://www.piplc.com/investor-relations/newsletters.

 

Ends

 

 

 

LEI: 2138001B3CE5S5PEE928

 

For more information please visit PIP's website at www.piplc.com or contact:

 

Andrew Lebus or Vicki Bradley

Pantheon

020 3356 1800

 

 

 

NOTES

PIP

PIP, a constituent of the FTSE 250, is a London quoted investment trust, managed by Pantheon Ventures (UK) LLP ("Pantheon"), a leading global private equity fund investor, investing in both primary funds and secondary transactions, and from time to time capitalising further on its fund investment activities by acquiring direct holdings in unquoted companies, usually either where a vendor is seeking to sell a combined portfolio of fund interests and direct holdings or where there is a private equity manager, well known to Pantheon, investing on substantially the same terms. By covering multiple private equity strategies ranging from investments in late stage buyouts to early stage venture, PIP enables individuals as well as institutions to gain access to a substantial portfolio of unquoted companies in the USA, the UK, Continental Europe and Asia, within funds managed by experienced private equity managers.

 

Pantheon

Pantheon is a leading global private equity fund investor that invests on behalf of over 400 institutional investors. Established over 35 years ago, Pantheon has developed a strong reputation and track record in primary, secondary and co-investments and across all stages and geographies. Pantheon has £28.8 billion in AUM***** (as at 31 March 2018), 256 employees, including 78 investment professionals, located across offices in London, San Francisco, New York, Hong Kong, Seoul, and Bogotá.

 

****\* This figure includes assets subject to discretionary or non-discretionary management, advice or those limited to a reporting function.

 

Neither the contents of PIP's website nor the contents of any website accessible from hyperlinks on PIP's website (or any other website) is incorporated into, or forms part of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSEFFMFFASEFA
Date   Source Headline
7th Aug 20197:05 amRNSAnnual Financial Report
7th Aug 20197:00 amRNSAppointment of Non-Executive Director
26th Jul 20197:00 amRNSMonthly Performance Update
11th Jul 20197:00 amRNSMonthly Performance Update
22nd May 20197:00 amRNSMonthly Performance Update
26th Apr 20197:00 amRNSMonthly Performance Update
26th Mar 20197:00 amRNSMonthly Performance Update
27th Feb 20197:00 amRNSHalf-year Report
26th Feb 20197:00 amRNSMonthly Performance Update
1st Feb 201911:37 amRNSTotal Voting Rights
25th Jan 20197:00 amRNSMonthly Performance Update
10th Jan 20196:05 pmRNSTotal Voting Rights
10th Jan 20196:03 pmRNSTransaction in Own Shares
10th Jan 201911:54 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSMonthly Performance Update
23rd Nov 20187:00 amRNSMonthly Performance Update
31st Oct 201812:02 pmRNSResult of AGM
23rd Oct 20187:00 amRNSMonthly Performance Update
26th Sep 20187:00 amRNSMonthly Performance Update
22nd Aug 20187:00 amRNSMonthly Performance Update
8th Aug 20187:00 amRNSAnnual Financial Report
31st Jul 20187:00 amRNSMonthly Performance Update
12th Jul 20187:00 amRNSMonthly Performance Update
11th Jul 201812:43 pmRNSDirector Declaration
5th Jun 20185:01 pmRNSDirector/PDMR Shareholding
4th Jun 20189:08 amRNSRenewal of Credit Facility
1st Jun 20182:44 pmRNSDirector/PDMR Shareholding
23rd May 20187:00 amRNSMonthly Performance Update
24th Apr 20187:00 amRNSMonthly Performance Update
5th Mar 20181:42 pmRNSDirector/PDMR Shareholding
5th Mar 20181:42 pmRNSDirector/PDMR Shareholding
2nd Mar 20184:43 pmRNSDirector Declaration
1st Mar 201811:54 amRNSDirector Declaration
27th Feb 20187:00 amRNSHalf-year Report
23rd Feb 20187:00 amRNSMonthly Performance Update
23rd Jan 20187:00 amRNSMonthly Performance Update
18th Jan 20189:15 amRNSDirector Declaration
12th Jan 20187:00 amRNSMonthly Performance Update
2nd Jan 20184:33 pmRNSTotal Voting Rights
7th Dec 20175:33 pmRNSTotal Voting Rights
7th Dec 20175:33 pmRNSTransaction in Own Shares
6th Dec 20175:52 pmRNSTotal Voting Rights
6th Dec 20175:49 pmRNSTransaction in Own Shares
4th Dec 20173:55 pmRNSDirector/PDMR Shareholding
1st Dec 201712:17 pmRNSTotal Voting Rights
24th Nov 20174:45 pmRNSTotal Voting Rights
24th Nov 20174:44 pmRNSTransaction in Own Shares
24th Nov 20177:05 amRNSTotal Voting Rights
24th Nov 20177:00 amRNSTransaction in Own Shares
22nd Nov 20173:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.